The study published in Neurology Clinical Practice states that people who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications.
A total of 25 percent of participants taking proton pump inhibitors had migraines or severe headaches, compared to 19 percent of those who were not taking the drugs. (Creative Commons)
Pantoprazole is a proton pump inhibitor (PPI) commonly prescribed to manage conditions such as gastroesophageal reflux disease. It reduces stomach acid production and promotes digestive tract healing. A study now finds PPIs are associated with an increased risk for migraine and other severe types of headaches.